Option Care Health Issues Statement On Optum Proposal For Amedisys
Portfolio Pulse from Benzinga Newsdesk
Option Care Health (NASDAQ: OPCH) filed a registration statement with the SEC for its proposed merger with Amedisys, reiterating its belief in the value creation opportunities for both companies. The all-stock transaction is expected to close in H2 2023, with the combined company generating over $500 million in annual cash flow by 2025 and $1 billion in combined Adjusted EBITDA by 2027.
June 05, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Option Care Health's proposed merger with Amedisys is expected to create significant value for both companies, with the combined entity generating over $500 million in annual cash flow by 2025 and $1 billion in combined Adjusted EBITDA by 2027.
The proposed merger between Option Care Health and Amedisys is expected to create significant value for both companies, as the combined entity will have a unique cash flow profile and be a differentiated leader in home health and alternate site care. The all-stock transaction allows stockholders of both companies to participate in the upside of the combined company, which is expected to generate substantial cash flow and EBITDA growth in the coming years. This is likely to have a positive short-term impact on OPCH's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100